IP Library Patent Application 11831024
Patent Application
App. No. 11/831,024

Self-Curing System For Endodontic Sealant Applications

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/831,024
Abstract

A two-part self-curing endodontic sealing system comprises a thiourea derivative, such as acetyl thiourea, and a hydroperoxide, such a cumene hydroperoxide. The thiourea derivative is used as a reducing agent and the hydroperoxide is used as an oxidizing agent.

Claims (29)

1 . A polymerizable two-part endodontic sealant composition comprising:

a first part comprising a hydroperoxide oxidizing agent in an amount from about 1% to 3% by weight;

a second part comprising a thiourea reducing agent in an amount from about 1% to 3% by weight; and

a polymerizable resin contained in at least the first part or the second part;

wherein the sealing composition comprises a calcium phosphate or calcium hydroxide filler; and

wherein the sealing composition is shelf-life stable at 50° C. for about four weeks.

2 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the hydroperoxide oxidizing agent has the formula R—OOH, wherein R is an aliphatic or aromatic group.

3 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the hydroperoxide oxidizing agent has the formula R—OOH, wherein R is an alkyl or aryl group.

4 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the hydroperoxide oxidizing agent has the formula R—OOH, wherein R t-butyl, cumyl, p-methane or p-isopropyl cumyl.

5 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the hydroperoxide oxidizing agent comprises cumene hydroperoxide.

6 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the thiourea reducing agent has the formula formula (R 1 R 2 N)C═S(NR 3 R 4 ), where R 1 , R 2 , R 3 , and R 4 can be H, a linear or cyclic alkyl, aryl, aralkyl, or allyl groups.

7 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the thiourea reducing agent comprises phenyl-thiourea, acetyl-thiourea, or ally-thiourea.

8 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the second part further comprises an acidic component.

9 . The polymerizable two-part endodontic sealant composition of claim 8 wherein the acidic component comprises an organic acid miscible in the polymerizable resin.

10 . The polymerizable two-part endodontic sealant composition of claim 9 wherein the organic acid comprises an acid having a carboxylic or phosphoric acid group attached.

11 . The polymerizable two-part endodontic sealant composition of claim 9 wherein the organic acid comprises methacrylic acid, pyromellitic dianhydrate glyceryl dimethacrylate (PMGDM), or 4-methacryloxyethyl trimellitic anhydride (4-META).

12 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the polymerizable resin comprises BIS-GMA, PUDMA, TEGDMA, PEGDMA, UDMA, HDDMA, PCDMA, PLAMA, HEMA, or mixtures thereof.

13 . The polymerizable two-part endodontic sealant composition of claim 14 wherein the calcium phosphate is calcium hydroxyapatite or amorphous calcium phosphate.

14 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the first part and the second part each comprises the polymerizable resin.

15 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the first part is present in the range of about 20 to about 80 percent by weight and the second part is present in the range of about 20 to about 80 percent.

16 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the first part comprises about 10 to about 60 percent by weight of a polymerizable resin, about 1 to about 10 percent by weight of a hydroperoxide oxidizing agent, and about 1 to about 80 percent by weight of a calcium phosphate or calcium hydroxide filler.

17 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the second part comprises about 10 to about 60 percent by weight of a polymerizable resin, about 1 to about 10 percent by weight of a thiourea reducing agent, and about 1 to about 80 percent by weight of a calcium phosphate or calcium hydroxide filler.

18 . The polymerizable two-part endodontic sealant composition of claim 22 wherein the second part comprises up to about 20 percent by weight of an organic acid miscible in the polymerizable resin.

19 . The polymerizable two-part endodontic sealant composition of claim 1 wherein the first part or the second part comprises one or more of a polymerization inhibitor, stabilizer, photoinitiator, redox initiator, radiopaque material, therapeutic agent, or mixtures thereof.

20 . The polymerizable two-part endodontic sealant composition of claim 19 wherein the therapeutic agent comprises an anesthetic, analgesic, antibiotic, anti-inflammatory antibacterial, antimicrobial, antifungal, aromatic, antihistamine, benzaldehyde, insulin, steroid, dentinal desensitizing, anti-neoplastic, agents, or mixtures thereof.

21 . The polymerizable two-part endodontic sealant composition of claim 20 wherein the antimicrobial agent is selected from the group consisting of benzalkonium chloride, iodoform, eugenol, zinc oxide, triclosan, butyl parahydroxybenzoate and mixtures thereof.

22 . The polymerizable two-part endodontic sealant composition of claim 19 wherein the polymerization inhibitor is selected from the group consisting of butylated hydroxytoluene, hydroquinone, hydroquinone monomethyl ether, benzoquinone, chloranil, and phenol.

23 . The polymerizable two-part endodontic sealant composition of claim 19 wherein the polymerization inhibitor is 2,6-di-tert-butyl-4-methylephenol.

24 . The polymerizable two-part endodontic sealant composition of claim 19 wherein the redox initiator comprises a benzoyl peroxide/amine system, perester/ascorbic acid system, perester/ascorbyl palmitate system, hydroperoxide/ascorbic acid system, hydroperoxide/ascorbyl palmitate system, (thio)barbitoric acid compound/copper halide system, or (thio)barbitoric acid compound/iron halide system.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2009
From: JIN, SHUHUA; JIA, WEITAO
To: PENTRON CLINICAL TECHNOLOGIES, LLC
Reel/Frame 022083/0693 →